Injectable Dosage (Subcutaneous or Intramuscular) Typical Range: 250500 mcg per day Administration: Inject subcutaneously near the injury site or systemically (abdomen) for full-body support Split doses (e.g., 250 mcg morning, 250 mcg evening) are common for sustained healing response Often used for 24 weeks , then cycled off or tapered depending on recovery progress BPC-157 promotes tendon outgrowth, cellular survival, and healing when administered directly into or near damaged soft tissues (Gwyer et al., Frontiers in Pharmacology)
The suppression of K63-ubiquitination of KEAP1 is mediated by OTU deubiquitinase 1 (OTUD1), which may inhibit ROS-induced oxeiptosis in kidney cancer cells [161]
Rahman I, Smith CA, Lawson MF, Harrison DJ, MacNee W: Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells
But the BPC spray has real perks that make it the top choice for many researchers: No Mixing Needed : Injectable peptides come as dry powder
